Aug 13

ASF invests in 3D Bio-Tissues

ASF Group has invested into an exciting new biotech opportunity being commercialised from intellectual property developed by Professor Che Connon from Newcastle University in the United Kingdom.

This groundbreaking biotech IP won the 2018 London Medical Design Gold Award and comprises a method wherein stem-cell-derived corneal collage production via 3D-printed constructs create improved corneal function in human cornea transplants.

ASF Group, together with Professor Connon, will plan for in vivo phases and animal trial phases of the IP.